{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T23:15:32Z","timestamp":1783552532320,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100019424","name":"Universidad de Santander","doi-asserted-by":"publisher","award":["Internal research grant No. 4530 (convocatoria interna UDES 2019)."],"award-info":[{"award-number":["Internal research grant No. 4530 (convocatoria interna UDES 2019)."]}],"id":[{"id":"10.13039\/100019424","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52530-7","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T03:36:28Z","timestamp":1778297788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Occult HBV among anti-HBc\u2013reactive blood donors in Colombia: low HBsAg prevalence, genotype F3, and small-S variation relevant to HBsAg detectability"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7746-6376","authenticated-orcid":false,"given":"Henry","family":"Bautista-Amorocho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Alexander","family":"Silva-Sayago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeny Zulay","family":"Castellanos-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"issue":"8","key":"52530_CR1","doi-asserted-by":"publisher","first-page":"e0272920","DOI":"10.1371\/journal.pone.0272920","volume":"17","author":"GR Takuissu","year":"2022","unstructured":"Takuissu, G. R. et al. Global epidemiology of occult hepatitis B virus infections in blood donors, a systematic review and meta-analysis. PLoS One. 17 (8), e0272920. https:\/\/doi.org\/10.1371\/journal.pone.0272920 (2022).","journal-title":"PLoS One"},{"issue":"3","key":"52530_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4254\/wjh.v7.i3.600","volume":"7","author":"DH Seo","year":"2015","unstructured":"Seo, D. H., Whang, D. H., Song, E. Y. & Han, K. S. Occult hepatitis B virus infection and blood transfusion. World J. Hepatol. 7 (3), 600\u2013606. https:\/\/doi.org\/10.4254\/wjh.v7.i3.600 (2015).","journal-title":"World J. Hepatol."},{"issue":"10 Pt 2","key":"52530_CR3","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1111\/trf.12218","volume":"53","author":"M Vermeulen","year":"2013","unstructured":"Vermeulen, M. et al. Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections. Transfusion 53 (10 Pt 2), 2459\u20132466. https:\/\/doi.org\/10.1111\/trf.12218 (2013).","journal-title":"Transfusion"},{"issue":"3","key":"52530_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/vox.12890","volume":"115","author":"H Scheiblauer","year":"2020","unstructured":"Scheiblauer, H. et al. Detection of hepatitis B virus infection in German blood donors 2008\u20132015. Vox Sang. 115 (3), 152\u2013161. https:\/\/doi.org\/10.1111\/vox.12890 (2020).","journal-title":"Vox Sang"},{"key":"52530_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12985-014-0206-z","volume":"11","author":"WA Rios-Ocampo","year":"2014","unstructured":"Rios-Ocampo, W. A., Cortes-Mancera, F., Olarte, J. C., Soto, A. & Navas, M. C. Occult hepatitis B virus infection among blood donors in Colombia. Virol. J. 11, 206. https:\/\/doi.org\/10.1186\/s12985-014-0206-z (2014).","journal-title":"Virol. J."},{"issue":"0","key":"52530_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7705\/biomedica.v38i3.3871","volume":"38","author":"D Pel\u00e1ez-Carvajal","year":"2018","unstructured":"Pel\u00e1ez-Carvajal, D., Forero, N. J., Escalante-Mora, M., Laiton-Donato, K. & Usme-Ciro, J. A. Genetic variability in coding regions of the surface antigen and reverse transcriptase domain of hepatitis B virus polymerase, Colombia, 2002\u20132014. Biomedica 38 (0), 37\u201350. https:\/\/doi.org\/10.7705\/biomedica.v38i3.3871 (2018).","journal-title":"Biomedica"},{"issue":"6","key":"52530_CR7","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3390\/v15061331","volume":"15","author":"F Sosa-Jurado","year":"2023","unstructured":"Sosa-Jurado, F. et al. Donated Blood Screening for HIV, HCV and HBV by ID-NAT and the Residual Risk of Iatrogenic Transmission in a Tertiary Care Hospital Blood Bank in Puebla, Mexico. Viruses 15 (6), 1331. https:\/\/doi.org\/10.3390\/v15061331 (2023).","journal-title":"Viruses"},{"key":"52530_CR8","doi-asserted-by":"publisher","first-page":"1874435","DOI":"10.1155\/2022\/1874435","volume":"2022","author":"Y Guo","year":"2022","unstructured":"Guo, Y. et al. The Investigation of HBV Pre-S\/S Gene Mutations in Occult HBV Infected Blood Donors with anti-HBs Positive. Can. J. Infect. Dis. Med. Microbiol. 2022, 1874435. https:\/\/doi.org\/10.1155\/2022\/1874435 (2022).","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"issue":"1","key":"52530_CR9","doi-asserted-by":"publisher","first-page":"8194","DOI":"10.1038\/s41598-022-12288-0","volume":"12","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. Molecular characteristics of the full-length genome of occult hepatitis B virus from blood donors in China. Sci. Rep. 12 (1), 8194. https:\/\/doi.org\/10.1038\/s41598-022-12288-0 (2022).","journal-title":"Sci. Rep."},{"key":"52530_CR10","unstructured":"World Health Organization. Screening donated blood for transfusion-transmissible infections: recommendations. Geneva: WHO. (2010). Available from: https:\/\/iris.who.int"},{"issue":"20","key":"52530_CR11","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310 (20), 2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053 (2013).","journal-title":"JAMA"},{"key":"52530_CR12","unstructured":"Ministerio de Salud de Colombia. Resoluci\u00f3n 008430 de 1993 (4 de octubre). Normas cient\u00edficas, t\u00e9cnicas y administrativas para la investigaci\u00f3n en salud. Bogot\u00e1: Ministerio de Salud. (1993). Available from: https:\/\/www.minsalud.gov.co"},{"issue":"2","key":"52530_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","volume":"71","author":"G Raimondo","year":"2019","unstructured":"Raimondo, G. et al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J. Hepatol. 71 (2), 397\u2013408 (2019). Epub 2019 Apr 18.","journal-title":"J. Hepatol."},{"key":"52530_CR14","doi-asserted-by":"publisher","first-page":"1202342","DOI":"10.3389\/fmicb.2023.1202342","volume":"14","author":"H Bautista-Amorocho","year":"2023","unstructured":"Bautista-Amorocho, H., Silva-Sayago, J. A. & Pic\u00f3n-Villamizar, J. High frequency of Lamivudine and Telbivudine resistance mutations in hepatitis B virus isolates from human immunodeficiency virus co-infected patients on highly active antiretroviral therapy in Bucaramanga, Colombia. Front. Microbiol. 14, 1202342. https:\/\/doi.org\/10.3389\/fmicb.2023.1202342 (2023).","journal-title":"Front. Microbiol."},{"issue":"5","key":"52530_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/vox.12770","volume":"114","author":"SA Fiedler","year":"2019","unstructured":"Fiedler, S. A. et al. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008\u20132015). Vox Sang. 114 (5), 443\u2013450.  (2019). Epub 2019 Apr 22.","journal-title":"Vox Sang"},{"key":"52530_CR16","doi-asserted-by":"publisher","unstructured":"Beltr\u00e1n, M. et al. Detecci\u00f3n de hepatitis B oculta en donantes de bancos sangre, Colombia 2008\u20132009 [Absence of occult hepatitis B in Colombian blood donors]. Biomedica. Spanish. (2011). Oct-Dec;31(4):580-9 https:\/\/doi.org\/10.1590\/S0120-41572011000400013","DOI":"10.1590\/S0120-41572011000400013"},{"key":"52530_CR17","doi-asserted-by":"publisher","first-page":"1368473","DOI":"10.3389\/fcimb.2024.1368473","volume":"14","author":"C He","year":"2024","unstructured":"He, C. et al. Frequency of HBsAg variants in occult hepatitis B virus infected patients and detection by ARCHITECT HBsAg quantitative. Front. Cell. Infect. Microbiol. 14, 1368473. https:\/\/doi.org\/10.3389\/fcimb.2024.1368473 (2024).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"52530_CR18","doi-asserted-by":"publisher","first-page":"e0265063","DOI":"10.1371\/journal.pone.0265063","volume":"17","author":"R Taherkhani","year":"2022","unstructured":"Taherkhani, R. & Farshadpour, F. Prevalence, genotype distribution and mutations of hepatitis B virus and the associated risk factors among pregnant women residing in the northern shores of Persian Gulf, Iran. PLoS One. 17 (3), e0265063. https:\/\/doi.org\/10.1371\/journal.pone.0265063 (2022).","journal-title":"PLoS One"},{"issue":"1","key":"52530_CR19","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.4102\/ajlm.v11i1.1677","volume":"11","author":"J Anejo-Okopi","year":"2022","unstructured":"Anejo-Okopi, J. et al. Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria. Afr. J. Lab. Med. 11 (1), 1677. https:\/\/doi.org\/10.4102\/ajlm.v11i1.1677 (2022).","journal-title":"Afr. J. Lab. Med."},{"issue":"16","key":"52530_CR20","doi-asserted-by":"publisher","first-page":"9049","DOI":"10.1128\/JVI.01161-14","volume":"88","author":"R Julithe","year":"2014","unstructured":"Julithe, R., Abou-Jaoud\u00e9, G. & Sureau, C. Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies. J. Virol. 88 (16), 9049\u20139059. https:\/\/doi.org\/10.1128\/JVI.01161-14 (2014).","journal-title":"J. Virol."},{"key":"52530_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.virol.2018.03.011","volume":"518","author":"X Bi","year":"2018","unstructured":"Bi, X. & Tong, S. Impact of immune escape mutations and N-linked glycosylation on the secretion of hepatitis B virus virions and subviral particles: Role of the small envelope protein. Virology 518, 358\u2013368. https:\/\/doi.org\/10.1016\/j.virol.2018.03.011 (2018).","journal-title":"Virology"},{"issue":"18","key":"52530_CR22","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1128\/JVI.00678-09","volume":"83","author":"J Salisse","year":"2009","unstructured":"Salisse, J. & Sureau, C. A function essential to viral entry underlies the hepatitis B virus a determinant. J. Virol. 83 (18), 9321\u20139328. https:\/\/doi.org\/10.1128\/JVI.00678-09 (2009).","journal-title":"J. Virol."},{"issue":"23","key":"52530_CR23","doi-asserted-by":"publisher","first-page":"12443","DOI":"10.1128\/JVI.01594-09","volume":"83","author":"Y Le Duff","year":"2009","unstructured":"Le Duff, Y., Blanchet, M. & Sureau, C. The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent. J. Virol. 83 (23), 12443\u201312451. https:\/\/doi.org\/10.1128\/JVI.01594-09 (2009).","journal-title":"J. Virol."},{"issue":"2","key":"52530_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1006\/viro.1995.1435","volume":"211","author":"CM Mangold","year":"1995","unstructured":"Mangold, C. M., Unckell, F., Werr, M. & Streeck, R. E. Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology 211 (2), 535\u2013543. https:\/\/doi.org\/10.1006\/viro.1995.1435 (1995).","journal-title":"Virology"},{"issue":"3","key":"52530_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.diagmicrobio.2016.04.004","volume":"85","author":"C Osiowy","year":"2016","unstructured":"Osiowy, C., Kowalec, K. & Giles, E. Discordant diagnostic results due to a hepatitis B virus T123A HBsAg mutant. Diagn. Microbiol. Infect. Dis. 85 (3), 328\u2013333. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.04.004 (2016).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"52530_CR26","doi-asserted-by":"publisher","first-page":"105431","DOI":"10.1016\/j.meegid.2023.105431","volume":"111","author":"JJ Han","year":"2023","unstructured":"Han, J. J., Hu, Y. A., Nan, Y., Chen, Y. & Yang, Y. L. Decreased expression of HBV surface antigen (HBsAg) with sK122R and sV96A co-mutation is associated with an ineffective antibody response in a chronic hepatitis B patient. Infect. Genet. Evol. 111, 105431. https:\/\/doi.org\/10.1016\/j.meegid.2023.105431 (2023).","journal-title":"Infect. Genet. Evol."},{"issue":"11","key":"52530_CR27","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s007050050240","volume":"142","author":"CM Mangold","year":"1997","unstructured":"Mangold, C. M., Unckell, F., Werr, M. & Streeck, R. E. Analysis of intermolecular disulfide bonds and free sulfhydryl groups in hepatitis B surface antigen particles. Arch. Virol. 142 (11), 2257\u20132267. https:\/\/doi.org\/10.1007\/s007050050240 (1997).","journal-title":"Arch. Virol."},{"issue":"10","key":"52530_CR28","doi-asserted-by":"publisher","first-page":"e0181643","DOI":"10.1371\/journal.pone.0181643","volume":"12","author":"CM Jaramillo","year":"2017","unstructured":"Jaramillo, C. M. et al. Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia. PLoS One. 12 (10), e0181643. https:\/\/doi.org\/10.1371\/journal.pone.0181643 (2017).","journal-title":"PLoS One"},{"issue":"1","key":"52530_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/pathogens13010046","volume":"13","author":"I Lazarevic","year":"2024","unstructured":"Lazarevic, I., Banko, A., Miljanovic, D., Cupic, M. & Hepatitis, B. Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies. Pathogens 13 (1), 46. https:\/\/doi.org\/10.3390\/pathogens13010046 (2024).","journal-title":"Pathogens"},{"key":"52530_CR30","doi-asserted-by":"publisher","unstructured":"Gencay, M. et al. May. Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population. PloS one 12,5 e0172101. 4 (2017). https:\/\/doi.org\/10.1371\/journal.pone.0172101","DOI":"10.1371\/journal.pone.0172101"},{"key":"52530_CR31","doi-asserted-by":"publisher","unstructured":"Choga, W. T. et al. Jul. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana. Viruses vol. 12,7 731. 6 (2020). https:\/\/doi.org\/10.3390\/v12070731","DOI":"10.3390\/v12070731"},{"issue":"1","key":"52530_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000445894","volume":"59","author":"H Chaouch","year":"2016","unstructured":"Chaouch, H. et al. Naturally Occurring Surface Antigen Variants of Hepatitis B Virus in Tunisian Patients. Intervirology 59 (1), 36\u201347. https:\/\/doi.org\/10.1159\/000445894 (2016).","journal-title":"Intervirology"},{"issue":"1","key":"52530_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12985-024-02366-2","volume":"21","author":"H Liu","year":"2024","unstructured":"Liu, H., Chen, S., Liu, X. & Lou, J. Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients. Virol. J. 21 (1), 92. https:\/\/doi.org\/10.1186\/s12985-024-02366-2 (2024).","journal-title":"Virol. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52530-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:37:02Z","timestamp":1783550222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52530-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52530"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52530-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol was reviewed and approved by the Universidad de Santander (UDES) Research Ethics Committee (Acta 2168-19). All procedures complied with the Declaration of Helsinki and Colombian regulations for biomedical research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all blood donors prior to donation and testing, in accordance with institutional and national regulations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"21246"}}